Recent lawsuits involving leading preterm formula makers may soon lead to these crucial products being pulled from shelves.

CVS Health owns Caremark and Cordavis, and its PBM's formulary contains a Cordavis-branded biosimilar. "Confusing? Absolutely. Profitable for the PBMs? Certainly. Good for plan sponsors and patients?

The FDA has urged baby formula manufacturers to make changes to how they make and test their products. Consumer Reports is ...

How the FDA is planning to bolster regulation, resilience and supply chain diversification across the infant formula market.

There were unforgiveable shortcomings in management, which included critical information not reaching senior officials as ...

The final text saw a number of legislative proposals culled in order to get it over the line, including measures that would have introduced stricter controls over the PBM sector that had been ...

Beginning this year, the test results must be publicly available on their websites for products made this year and beyond.

I will be using ByHeart as long as my baby is on formula.” “A formula so clean, we won awards for it,” is how Bobbie — a mom-founded company — markets its products, which include this ...

A bundle of healthcare legislation that would introduce greater oversight of the pharmacy benefit manager (PBM) sector is reported to be close to an agreement by US lawmakers. The package ...

The ongoing baby formula shortage that is frustrating parents all across the country has gone from bad to worse over the past week, according to a new report by Bloomberg,... President Joe Biden ...